These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37861001)

  • 1. Glucose Transporter and Sensor Mechanisms in Fungal Pathogens as Potential Drug Targets.
    Navale AM
    Curr Rev Clin Exp Pharmacol; 2024; 19(3):250-258. PubMed ID: 37861001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungals discovery: an insight into new strategies to combat antifungal resistance.
    Fuentefria AM; Pippi B; Dalla Lana DF; Donato KK; de Andrade SF
    Lett Appl Microbiol; 2018 Jan; 66(1):2-13. PubMed ID: 29112282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal drug resistance: evolution, mechanisms and impact.
    Revie NM; Iyer KR; Robbins N; Cowen LE
    Curr Opin Microbiol; 2018 Oct; 45():70-76. PubMed ID: 29547801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential targets for the development of new antifungal drugs.
    Su H; Han L; Huang X
    J Antibiot (Tokyo); 2018 Nov; 71(12):978-991. PubMed ID: 30242283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies.
    Mota Fernandes C; Del Poeta M
    Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1083-1092. PubMed ID: 32673125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Stress Response Pathways with Alternative Strategies as a Novel Antifungal Approach.
    Ruhil S; Kumar V; Balhara M; Malik M; Chhillar AK
    Mini Rev Med Chem; 2021; 21(16):2337-2346. PubMed ID: 33749563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier-Mediated Drug Uptake in Fungal Pathogens.
    Galocha M; Costa IV; Teixeira MC
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33182427
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting efflux pumps to overcome antifungal drug resistance.
    Holmes AR; Cardno TS; Strouse JJ; Ivnitski-Steele I; Keniya MV; Lackovic K; Monk BC; Sklar LA; Cannon RD
    Future Med Chem; 2016 Aug; 8(12):1485-501. PubMed ID: 27463566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fungal resistome: a risk and an opportunity for the development of novel antifungal therapies.
    Reales-Calderón JA; Molero G; Gil C; Martínez JL
    Future Med Chem; 2016 Aug; 8(12):1503-20. PubMed ID: 27485839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global problem of antifungal resistance: prevalence, mechanisms, and management.
    Perlin DS; Rautemaa-Richardson R; Alastruey-Izquierdo A
    Lancet Infect Dis; 2017 Dec; 17(12):e383-e392. PubMed ID: 28774698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungals.
    Campoy S; Adrio JL
    Biochem Pharmacol; 2017 Jun; 133():86-96. PubMed ID: 27884742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipids as targets for treatment of fungal infections.
    Rollin-Pinheiro R; Singh A; Barreto-Bergter E; Del Poeta M
    Future Med Chem; 2016 Aug; 8(12):1469-84. PubMed ID: 27502288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Antifungal Agents: Current Status and Projected Future Developments.
    Seyedmousavi S; Rafati H; Ilkit M; Tolooe A; Hedayati MT; Verweij P
    Methods Mol Biol; 2017; 1508():107-139. PubMed ID: 27837500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How do fungal infections "escape" treatment? Resistance and resistance mechanisms].
    Morschhäuser J
    Pharm Unserer Zeit; 2003; 32(2):124-8. PubMed ID: 12677965
    [No Abstract]   [Full Text] [Related]  

  • 15. Antifungal drug resistance: does it matter?
    Rogers TR
    Int J Infect Dis; 2002 Mar; 6 Suppl 1():S47-53. PubMed ID: 12044289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein inhibitors for the treatment of fungal infections.
    Wirk B
    Recent Pat Antiinfect Drug Discov; 2011 Jan; 6(1):38-44. PubMed ID: 21192778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi.
    Parente-Rocha JA; Bailão AM; Amaral AC; Taborda CP; Paccez JD; Borges CL; Pereira M
    Mediators Inflamm; 2017; 2017():9870679. PubMed ID: 28694566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal Drugs: The Current Armamentarium and Development of New Agents.
    Robbins N; Wright GD; Cowen LE
    Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27763259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress and prospects for targeting Hsp90 to treat fungal infections.
    Veri A; Cowen LE
    Parasitology; 2014 Aug; 141(9):1127-37. PubMed ID: 24560124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies in the discovery of novel antifungal scaffolds.
    Liu N; Wang C; Su H; Zhang W; Sheng C
    Future Med Chem; 2016 Aug; 8(12):1435-54. PubMed ID: 27463376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.